NCT06138002

Brief Summary

Low Back Pain (LBP) is one of the common causes of morbidity worldwide, with a one-month prevalence of 23.3 %. Number of people with LBP reached 577 million people in 2020. LBP has been the leading cause of years lived with disability from 1990 to 2017. The highest incidence of LBP is in people in their third decade of age. LBP is a complex disease difficult to treat as most of these cases (80 - 90 %) are classified as non-specific meaning that the pain cannot be attributed to any specific injury or pathology. Until now exercise therapy is commonly used as the treatment of choice in the revalidation program of LBP. The aim of physical treatment is to improve function and prevent disability from getting worse. LumbaCure® is a robotic system driven by a proprietary movement algorithm to induce a specific and controlled mobilization of the hips and the low back in patient requiring treatment by physical exercises due to orthopedic disorder, especially low back pain. The investigation include an intervention period of 4 weeks The main objective is to compare the impact on disability (Oswestry disability Index) and movement performance of the interventions (LumbaCure® vs physical exercises supervised by the physiotherapist) in two parallel groups of patients suffering from chronic low back pain. The investigation includes an intervention period of 4 weeks and a follow-up period of 6 months (post intervention period).

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
22

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Oct 2023

Geographic Reach
1 country

2 active sites

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 2, 2023

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

November 8, 2023

Completed
10 days until next milestone

First Posted

Study publicly available on registry

November 18, 2023

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 8, 2024

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 12, 2024

Completed
Last Updated

October 18, 2024

Status Verified

November 1, 2023

Enrollment Period

5 months

First QC Date

November 8, 2023

Last Update Submit

October 16, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Disability

    The change of the Oswestry Disability Index (ODI) between baseline and the end of the intervention period (4 weeks)

    Baseline, week 4 (end of intervention period)

Secondary Outcomes (16)

  • Disability

    week2 (intervention period); month 1, month 3 and month 6 follow-up period

  • Disability responding rate

    week 2, week 4 (intervention period) and at month 1, month 3 and month 6 follow-up period

  • Back Pain

    week 1, week 2, week 3 and week 4 (the intervention period)

  • Back Pain

    month 1, month 3 and month 6 (follow-up period)

  • Back Pain responding rate

    week 2, week 4 (intervention period) and at month 1, month 3 and month 6 (follow-up period)

  • +11 more secondary outcomes

Other Outcomes (7)

  • Patient mobilization

    LumbaCure® session 1 and session 12 : Week 1 (Day 0) and Week 4 (Day 25)

  • Measurement in Dynamic/static situation

    Baseline and week 4 (end of intervention period)

  • Measurement in Dynamic/static situation

    Baseline and week 4 (end of intervention period)

  • +4 more other outcomes

Study Arms (2)

Test Intervention arm

EXPERIMENTAL

The LumbaCure® is a robotic system which provide active, specific and controlled mobilization of the low back. The device is to be used by the Physiotherapist at the rehabilitation centre. The duration of a session for the patient is 15 minutes. Patients follow a serie of 12 consecutive LumbaCure® sessions at a frequency of 3 sessions / week for 4 weeks.

Device: LumbaCure®

Control Intervention arm

ACTIVE COMPARATOR

A set of core stability exercises/active qualitative mobilization has been defined with principal investigator according to the standard of care at Investigator site. At each session, 5 exercises will be selected by the investigator depending on the evolution and pathology of the patient. Five minutes of warm-up will be performed before starting the exercises session. The program will last 15 to 30 min depending on the time required for the patient to complete the prescribed exercises. Patients follow a serie of 12 consecutive physical exercises sessions at a frequency of 3 sessions / week for 4 weeks.

Procedure: Physical Exercises supervised by the physiotherapist

Interventions

LumbaCure®is a robotic system that systematically moves the spine of affected patients with a complex proprietary algorithm.

Test Intervention arm

A set of core stability/active qualitative mobilization exercises have been defined, corresponding to standard exercises proposed in center rehabilitation program

Control Intervention arm

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Chronic non-specific LBP (without red flag)
  • Patient did not increase, on a long-term basis, his/her regular physical activity in the past 2 months.
  • LBP is the principal musculoskeletal condition
  • Aged between 18 and 65 years old
  • Able to read and understand questionnaires and communicate with the physiotherapist.
  • Average Back Pain intensity over the last week above 2, assessed on Numerical Pain Rating Scale from 0 to 10 anchored with "no pain" at 0 and "worst pain imaginable " at 10.
  • ODI score \> 20

You may not qualify if:

  • Suspected or confirmed serious pathology (i.e infection, fracture, cancer, inflammatory arthritis, ….)
  • Radicular pain
  • Radiculopathy
  • Cognitive impairment that precludes participant from consenting, completing investigation questionnaires or complying with recommendations
  • Previous spine surgery in the last 3 months
  • Pregnant women
  • body weight \> 120 kg
  • Neurological disease
  • Fibromyalgia

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Jessa Ziekenhuis vzw

Hasselt, 3500, Belgium

Location

Jessa Ziekenhuis vzw

Herk-de-Stad, 3540, Belgium

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 8, 2023

First Posted

November 18, 2023

Study Start

October 2, 2023

Primary Completion

March 8, 2024

Study Completion

September 12, 2024

Last Updated

October 18, 2024

Record last verified: 2023-11

Data Sharing

IPD Sharing
Will not share

Locations